Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of Using LabPad® Point-of-care to Measure International Normalized Ratio (INR) at Home on the Patient's Follow up on VKA

NCT04117048 is registered in ClinicalTrials.gov with Medicalps as lead sponsor.

NCT NCT04117048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04117048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of Using LabPad® Point-of-care to Measure International Normalized Ratio (INR) at Home on the Patient's Follow up on VKA
Lead sponsor
Medicalps
Phase
Not applicable
Overall status
Completed
Start date
October 3, 2019
Completion date
April 3, 2020
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

international normalized ratio (inr) measure at home, thromboembolic pathology, vitamine k antagonist (vka) treatment